Theriva Biologics, Inc. (TOVX) Misses Q2 EPS by 24c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q2 EPS of ($0.43), $0.24 worse than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• MGM Resorts (MGM) PT Raised to $55 at Argus